Analysis Lime Chemicals Limited (LIMECHM)
6/5/2024
Analysis of Lime Chemicals Limited (LIMECHM)
Lime Chemicals Limited has been showing some fluctuations in its stock price recently. The Relative Strength Index (RSI) values have been hovering around the mid-range, indicating a neutral sentiment in the market. The Moving Average Convergence Divergence (MACD) indicator has been negative, suggesting a bearish trend.The stock price has been moving below the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) values, indicating a downward trend. However, the MACD histogram has shown some signs of stabilization in recent days.
Overall, Lime Chemicals Limited seems to be experiencing some bearish pressure in the short term, but investors should keep an eye on the MACD histogram for any potential trend reversal signals.
Main Statystic ðŸ§
The data provides a comprehensive overview of the financial and stock-related metrics for a company. Here are the key points:1. **Financials**:
- **Cash Flow**: Operating cash flow (TTM) is $110.56 billion, and levered free cash flow (TTM) is $84.73 billion.
- **Balance Sheet**: Total cash (MRQ) is $67.15 billion, total debt (MRQ) is $104.59 billion, current ratio (MRQ) is 1.037, book value per share (MRQ) is $4.837, total cash per share (MRQ) is $4.379, and total debt to equity ratio (MRQ) is 140.968.
- **Profit Margin**: The profit margin is 26.31%.
- **Income Statement**: EBITDA is $131.39 billion, revenue (TTM) is $381.62 billion, diluted EPS (TTM) is $6.43, gross profit (TTM) is $169.15 billion, revenue per share (TTM) is $24.537, net income to common (TTM) is $100.39 billion, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- **Margins**: Operating margin is 30.74%.
- **Returns**: Return on assets (TTM) is 22.07%, and return on equity (TTM) is 147.25%.
2. **Stock Statistics**:
- **Shares**: Float shares are 15.31 billion, shares short are 99.29 million, average 10-day volume is 46.86 million, average 90-day volume is 57.50 million, shares outstanding are 15.33 billion.
- **Ownership**: Percent held by insiders is 5.22%, percent held by institutions is 57.59%, short percent of shares outstanding is 0.65%.
3. **Valuation Metrics**:
- **Ratios**: PEG ratio is 26.32, forward PE is 26.32, trailing PE is 29.59, price to book (MRQ) is 39.34, price to sales (TTM) is 7.65, enterprise value is $2.95 trillion, enterprise to EBITDA is 22.76, and enterprise to revenue is 7.73.
- **Market Cap**: Market capitalization is $2.92 trillion.
4. **Stock Price Summary**:
- **Performance**: Beta is 1.264, 50-day moving average is $176.26, 200-day moving average is $181.04, 52-week low is $164.08, 52-week high is $199.62, and 52-week change is 6.85%.
5. **Dividends and Splits**:
- **Dividends**: Payout ratio is 14.93%, dividend date is 05/16/2024, ex-dividend date is 05/10/2024, forward annual dividend rate is $1, 5-year average dividend yield is 0.73%, forward annual dividend yield is 0.53%, trailing annual dividend rate is $0.97, and trailing annual dividend yield is 0.51%. Last split date was 08/31/2020, and the last split factor was a 4-for-1 split.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management.
3. The gross profit margin has remained relatively stable over the years, indicating efficient cost control measures.
4. Earnings before interest and taxes (EBIT) have shown an increasing trend, reaching $117.7 billion in 2023.
5. Net income has also been increasing, reaching $97 billion in 2023.
6. The company has been able to maintain a consistent number of outstanding shares over the years.
7. Overall, the financial performance of the company seems to be improving, with increasing revenues and profitability.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2019 at $90,488,000,000.
6. The company has been relying more on non-current assets to finance its operations over the years.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS):1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous year.
4. For the next year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a growth trajectory from the EPS of $6.10 in the current year.
Overall, the analysts' estimates point towards a positive outlook for the company's earnings per share, showing a trend of expected growth in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are generally optimistic about the company's future sales performance, with moderate growth expected in both the quarterly and annual sales figures.
Growth estimates
Based on the consensus estimates provided:- The company is expected to experience a growth rate of 7.6% in the current year and 9.7% in the next year.
- For the current quarter and the next quarter, the growth rate is estimated to be around 5.1%.
- Over the next 5 years, the company is projected to have a compound annual growth rate (CAGR) of approximately 9.7%.
- However, in the past 5 years, the company had a higher growth rate of around 20.1% per annum.
Overall, it seems that the company is expected to maintain a solid growth trajectory, with a slightly higher growth rate in the next 5 years compared to the current and previous periods.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median estimate of $201.43 and an average estimate of $204.58. However, it's worth noting that there is a wide range of forecasts, from a low of $164 to a high of $275. The current price of the security is $192.25, which is below both the median and average forecasted prices.
MACD of LIMECHM
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
